Singhania & Co. Advises Anondita Medicare On ₹69.5 Crore SME IPO Listing

Singhania & Co. acted as the legal counsel to Anondita Medicare Limited in connection with its SME IPO of ₹69.5 crores. The issue witnessed a response from investors, being oversubscribed by over 300 times. The IPO was priced at ₹145 per share and listed at ₹275.50 per share on the stock exchanges.

Narnolia Financial Services Limited acted as the Book Running Lead Manager (BRLM), with Krishna N Narnolia, Shailendra Kumar, Ameet S Kishorpuria and Tarun Tiwari leading the team, while Maashitla Securities Private Limited acted as the Registrar to the Issue.

Founded in March 2024, Anondita Medicare Limited manufactures male contraceptives, with its flagship product branded as “COBRA.” The company produces 562 million contraceptives annually. The company has a manufacturing facility situated in Noida, Uttar Pradesh. Anondita Medicare exports its products to several international markets, including Southeast Asia, Africa, and the Middle East. The company collaborates with global health organizations, NGOs, and governments to support family planning and public health initiatives.

The transaction was led by Rohit Jain (Managing Partner), Diviay Chadha (Partner), Apoorva Kuthiala (Principal Associate), and Utkarsh Gaba (Senior Associate)

Singhania & Co. (S&Co.) is a full-service law firm with over 50+ years of legacy. S&Co has established itself as one of the law firms in the country rendering legal services across various practice areas, including capital markets, general corporate, mergers and acquisitions, tax, finance, Pharma & Health, Infrastructure, IP, dispute resolution, investment funds and international trade. .